glp 1 agonist weight loss comparison Lilly orforglipron oral GLP-1 phase 3 trial GLP-1R Agonists for Weight Loss

The prevalence of T2DM is elevated in patients with HD [830], suggesting that impaired insulin sensitivity might be a causal factor contributing to neurodegeneration in HD patients [830,831]

GLP-1 RAs were created after endogenous glucagon-like peptide-1 (GLP-1) was discovered in the 1980s by Jens Juul Host and Joel Habener [1,2]

Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity

Similar neuroprotective effects have been reported in various PD rodent models treated with GLP-1R agonists [[844], [845], [846], [847], [848], [849]]

The Dangerous Side Effects of Ozempic While weight loss can bring about significant health benefits, it's important to note that rapid weight loss can have negative consequences, including a decrease in muscle mass, lower bone density, and a decrease in resting metabolic rate (RMR)

Recent research has raised significant concerns about accelerated bone density loss in GLP-1 users